| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GLRA3 OR4D1 OR14K1 TRPV4 OR8H1 TRPV1 ADRA2B CSF1R ADGRF1 OR13C3 OR6N1 GLRA1 OR8K5 OR9A1P | 2.42e-08 | 1353 | 35 | 14 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.88e-08 | 459 | 35 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | calcium channel activity | 9.00e-08 | 129 | 35 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | channel activity | 2.15e-07 | 525 | 35 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.19e-07 | 526 | 35 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.29e-07 | 151 | 35 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GLRA3 TRPV2 TRPV4 CATSPER3 TRPV1 TMC2 SLC24A4 SLC31A2 TMC3 GLRA1 | 6.86e-07 | 793 | 35 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | gated channel activity | 1.55e-06 | 334 | 35 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GLRA3 TRPV2 TRPV4 CATSPER3 TRPV1 TMC2 SLC24A4 SLC31A2 SLCO1B1 TMC3 GLRA1 | 3.28e-06 | 1180 | 35 | 11 | GO:0022857 |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 3.95e-06 | 18 | 35 | 3 | GO:0008381 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 4.54e-06 | 758 | 35 | 9 | GO:0015318 | |
| GeneOntologyMolecularFunction | transporter activity | GLRA3 TRPV2 TRPV4 CATSPER3 TRPV1 TMC2 SLC24A4 SLC31A2 SLCO1B1 TMC3 GLRA1 | 7.67e-06 | 1289 | 35 | 11 | GO:0005215 |
| GeneOntologyMolecularFunction | olfactory receptor activity | 8.29e-06 | 431 | 35 | 7 | GO:0004984 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.36e-05 | 465 | 35 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 1.57e-05 | 884 | 35 | 9 | GO:0004930 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.62e-05 | 343 | 35 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 4.46e-05 | 6 | 35 | 2 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 4.46e-05 | 6 | 35 | 2 | GO:0016934 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 5.80e-05 | 43 | 35 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 7.11e-05 | 46 | 35 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | inhibitory extracellular ligand-gated monoatomic ion channel activity | 8.30e-05 | 8 | 35 | 2 | GO:0005237 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 9.10e-05 | 627 | 35 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.30e-04 | 664 | 35 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | glycine binding | 2.68e-04 | 14 | 35 | 2 | GO:0016594 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 3.30e-04 | 77 | 35 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | odorant binding | 1.42e-03 | 127 | 35 | 3 | GO:0005549 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.37e-03 | 152 | 35 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 3.47e-03 | 50 | 35 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.93e-03 | 182 | 35 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.06e-03 | 184 | 35 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.63e-03 | 193 | 35 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.91e-03 | 197 | 35 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.79e-03 | 65 | 35 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.79e-03 | 65 | 35 | 2 | GO:0022824 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 5.97e-03 | 66 | 35 | 2 | GO:0005080 | |
| GeneOntologyMolecularFunction | amino acid binding | 7.26e-03 | 73 | 35 | 2 | GO:0016597 | |
| GeneOntologyMolecularFunction | calmodulin binding | 7.52e-03 | 230 | 35 | 3 | GO:0005516 | |
| GeneOntologyMolecularFunction | chloride channel activity | 9.95e-03 | 86 | 35 | 2 | GO:0005254 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.33e-02 | 100 | 35 | 2 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.40e-02 | 103 | 35 | 2 | GO:0005253 | |
| GeneOntologyBiologicalProcess | sensory perception | OR4D1 TRPV2 OR14K1 ULK4 OR8H1 TRPV1 TMC2 SLC24A4 OR13C3 OR6N1 GLRA1 OR8K5 OR9A1P RNF170 | 8.02e-10 | 1072 | 35 | 14 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR4D1 OR14K1 OR8H1 TRPV1 TMC2 SLC24A4 OR13C3 OR6N1 OR8K5 OR9A1P | 2.88e-08 | 582 | 35 | 10 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 8.37e-08 | 485 | 35 | 9 | GO:0050907 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 1.61e-07 | 524 | 35 | 9 | GO:0009593 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR4D1 OR14K1 OR8H1 TRPV1 TMC2 SLC24A4 OR13C3 OR6N1 OR8K5 OR9A1P | 2.16e-07 | 722 | 35 | 10 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 2.32e-07 | 547 | 35 | 9 | GO:0007606 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 4.97e-07 | 432 | 35 | 8 | GO:0050911 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 8.66e-07 | 465 | 35 | 8 | GO:0007608 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.28e-06 | 48 | 35 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.28e-06 | 48 | 35 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR4D1 OR14K1 OR8H1 ADRA2B SLC24A4 ADGRF1 ADCY6 OR13C3 OR6N1 GLRA1 OR8K5 OR9A1P | 1.69e-06 | 1395 | 35 | 12 | GO:0007186 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GLRA3 TRPV2 TRPV4 CATSPER3 TRPV1 TMC2 SLC24A4 SLC31A2 SLCO1B1 TMC3 GLRA1 | 1.04e-05 | 1374 | 35 | 11 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GLRA3 TRPV2 TRPV4 CATSPER3 TRPV1 TMC2 SLC24A4 SLC31A2 TMC3 GLRA1 | 1.09e-05 | 1115 | 35 | 10 | GO:0034220 |
| GeneOntologyBiologicalProcess | calcium ion import | 2.24e-05 | 98 | 35 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 3.67e-05 | 1017 | 35 | 9 | GO:0098660 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 4.62e-05 | 392 | 35 | 6 | GO:0070588 | |
| GeneOntologyBiologicalProcess | adult walking behavior | 8.31e-05 | 50 | 35 | 3 | GO:0007628 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 9.55e-05 | 142 | 35 | 4 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 9.55e-05 | 142 | 35 | 4 | GO:0098659 | |
| GeneOntologyBiologicalProcess | walking behavior | 1.43e-04 | 60 | 35 | 3 | GO:0090659 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.94e-04 | 509 | 35 | 6 | GO:0006816 | |
| GeneOntologyBiologicalProcess | diet induced thermogenesis | 3.74e-04 | 17 | 35 | 2 | GO:0002024 | |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 4.12e-04 | 208 | 35 | 4 | GO:0009266 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 4.83e-04 | 217 | 35 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 6.01e-04 | 230 | 35 | 4 | GO:0098739 | |
| GeneOntologyBiologicalProcess | neuromuscular process controlling posture | 6.33e-04 | 22 | 35 | 2 | GO:0050884 | |
| GeneOntologyBiologicalProcess | neuroinflammatory response | 6.66e-04 | 101 | 35 | 3 | GO:0150076 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 7.82e-04 | 922 | 35 | 7 | GO:0098662 | |
| GeneOntologyBiologicalProcess | cellular response to ethanol | 8.19e-04 | 25 | 35 | 2 | GO:0071361 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage chemotaxis | 8.86e-04 | 26 | 35 | 2 | GO:0010759 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 8.87e-04 | 942 | 35 | 7 | GO:0098655 | |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 9.95e-04 | 116 | 35 | 3 | GO:0008344 | |
| GeneOntologyBiologicalProcess | cellular response to zinc ion | 1.03e-03 | 28 | 35 | 2 | GO:0071294 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.26e-03 | 1000 | 35 | 7 | GO:0030001 | |
| GeneOntologyBiologicalProcess | reflex | 1.26e-03 | 31 | 35 | 2 | GO:0060004 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.38e-03 | 130 | 35 | 3 | GO:0060079 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 1.38e-03 | 130 | 35 | 3 | GO:0097306 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage migration | 1.43e-03 | 33 | 35 | 2 | GO:1905523 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level water homeostasis | 1.61e-03 | 35 | 35 | 2 | GO:0050891 | |
| GeneOntologyBiologicalProcess | regulation of macrophage chemotaxis | 1.79e-03 | 37 | 35 | 2 | GO:0010758 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.96e-03 | 147 | 35 | 3 | GO:0099565 | |
| GeneOntologyCellularComponent | cell surface | 4.04e-04 | 1111 | 35 | 8 | GO:0009986 | |
| GeneOntologyCellularComponent | glycinergic synapse | 5.08e-04 | 20 | 35 | 2 | GO:0098690 | |
| MousePheno | abnormal nociception after inflammation | 4.93e-05 | 44 | 23 | 3 | MP:0002736 | |
| MousePheno | abnormal muscle physiology | 8.89e-05 | 954 | 23 | 8 | MP:0002106 | |
| MousePheno | abnormal sensory neuron physiology | 2.15e-04 | 72 | 23 | 3 | MP:0010055 | |
| MousePheno | increased blood osmolality | 3.06e-04 | 16 | 23 | 2 | MP:0008997 | |
| MousePheno | abnormal touch/ nociception | 3.09e-04 | 376 | 23 | 5 | MP:0001968 | |
| MousePheno | abnormal somatic nervous system physiology | 3.28e-04 | 83 | 23 | 3 | MP:0005423 | |
| MousePheno | abnormal blood osmolality | 3.47e-04 | 17 | 23 | 2 | MP:0008996 | |
| Domain | TRPV1-4_channel | 1.83e-08 | 4 | 32 | 3 | IPR008347 | |
| Domain | TRP_channel | 7.47e-07 | 11 | 32 | 3 | IPR004729 | |
| Domain | TRPV4_channel | 2.84e-06 | 2 | 32 | 2 | IPR008348 | |
| Domain | Glycine_rcpt_A | 1.70e-05 | 4 | 32 | 2 | IPR008127 | |
| Domain | Ion_trans_dom | 4.15e-05 | 114 | 32 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.15e-05 | 114 | 32 | 4 | PF00520 | |
| Domain | Olfact_rcpt | 4.76e-05 | 393 | 32 | 6 | IPR000725 | |
| Domain | TMC | 7.91e-05 | 8 | 32 | 2 | PF07810 | |
| Domain | TMC | 7.91e-05 | 8 | 32 | 2 | IPR012496 | |
| Domain | 7tm_1 | 1.22e-04 | 677 | 32 | 7 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.31e-04 | 685 | 32 | 7 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.38e-04 | 691 | 32 | 7 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.39e-04 | 692 | 32 | 7 | IPR000276 | |
| Domain | GABAA/Glycine_rcpt | 7.04e-04 | 23 | 32 | 2 | IPR006028 | |
| Domain | GPCR_Rhodpsn_7TM | 8.51e-04 | 670 | 32 | 6 | IPR017452 | |
| Domain | Neurotransmitter_ion_chnl_CS | 2.69e-03 | 45 | 32 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 2.81e-03 | 46 | 32 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 2.93e-03 | 47 | 32 | 2 | PF02931 | |
| Domain | Neur_channel | 2.93e-03 | 47 | 32 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.93e-03 | 47 | 32 | 2 | IPR006202 | |
| Domain | Neurotrans-gated_channel_TM | 2.93e-03 | 47 | 32 | 2 | IPR006029 | |
| Domain | NEUROTR_ION_CHANNEL | 2.93e-03 | 47 | 32 | 2 | PS00236 | |
| Domain | - | 2.93e-03 | 47 | 32 | 2 | 2.70.170.10 | |
| Domain | Ank | 6.86e-03 | 228 | 32 | 3 | PF00023 | |
| Domain | - | 8.64e-03 | 248 | 32 | 3 | 1.25.40.20 | |
| Domain | ANK | 8.92e-03 | 251 | 32 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 9.12e-03 | 253 | 32 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 9.22e-03 | 254 | 32 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 9.22e-03 | 254 | 32 | 3 | PS50297 | |
| Domain | Ankyrin_rpt | 1.00e-02 | 262 | 32 | 3 | IPR002110 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.57e-05 | 28 | 25 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.57e-05 | 28 | 25 | 3 | M27241 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 7.10e-05 | 417 | 25 | 6 | M4072 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 8.68e-05 | 636 | 25 | 7 | M41834 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 3.57e-04 | 16 | 25 | 2 | M39849 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 5.25e-04 | 389 | 25 | 5 | M14091 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 6.91e-04 | 99 | 25 | 3 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.43e-04 | 106 | 25 | 3 | M27200 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.25e-03 | 272 | 25 | 4 | M13380 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.50e-03 | 736 | 25 | 6 | M27287 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 1.54e-03 | 33 | 25 | 2 | MM15058 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 1.59e-03 | 132 | 25 | 3 | M48110 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.04e-03 | 144 | 25 | 3 | MM14501 | |
| Pubmed | Thermosensitive transient receptor potential channels in human corneal epithelial cells. | 9.34e-10 | 3 | 35 | 3 | 21506114 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 22327830 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 28158279 | ||
| Pubmed | Expression of transient receptor potential vanilloid (TRPV) 1, 2, 3, and 4 in mouse inner ear. | 9.34e-10 | 3 | 35 | 3 | 18607942 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 19839244 | ||
| Pubmed | Nicotinic acid is a common regulator of heat-sensing TRPV1-4 ion channels. | 3.73e-09 | 4 | 35 | 3 | 25752528 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 25333484 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 18787888 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 18983665 | ||
| Pubmed | TRPV3 is a temperature-sensitive vanilloid receptor-like protein. | 9.32e-09 | 5 | 35 | 3 | 12077606 | |
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 18701070 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 31229503 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 25069877 | ||
| Pubmed | TRPV1 and TRPV4 play pivotal roles in delayed onset muscle soreness. | 9.84e-07 | 2 | 35 | 2 | 23799042 | |
| Pubmed | Characterization of the glycinergic input to bipolar cells of the mouse retina. | 9.84e-07 | 2 | 35 | 2 | 16420443 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 26314785 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 23964684 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24641282 | ||
| Pubmed | Trpv4 Mediates Hypotonic Inhibition of Central Osmosensory Neurons via Taurine Gliotransmission. | 9.84e-07 | 2 | 35 | 2 | 29791836 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 33664402 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 25449039 | ||
| Pubmed | Nociceptors lacking TRPV1 and TRPV2 have normal heat responses. | 9.84e-07 | 2 | 35 | 2 | 15254097 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 29733975 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 30761248 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 21832173 | ||
| Pubmed | The Roles of Transient Receptor Potential Vanilloid 1 and 4 in Olfactory Regeneration. | 9.84e-07 | 2 | 35 | 2 | 36870285 | |
| Pubmed | TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis. | 9.84e-07 | 2 | 35 | 2 | 23021218 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 21486794 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 16115206 | ||
| Pubmed | Trafficking of Stretch-Regulated TRPV2 and TRPV4 Channels Inferred Through Interactomics. | 9.84e-07 | 2 | 35 | 2 | 31783610 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 16777226 | ||
| Pubmed | Phosphorylation of α3 glycine receptors induces a conformational change in the glycine-binding site. | 9.84e-07 | 2 | 35 | 2 | 23834509 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20639579 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 29018170 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 26146187 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 25100078 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 35437956 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 21562271 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24155319 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 34884463 | ||
| Pubmed | Targeting TRPV1 and TRPV2 for potential therapeutic interventions in cardiovascular disease. | 9.84e-07 | 2 | 35 | 2 | 23453732 | |
| Pubmed | Comparative Analysis of Single-Molecule Dynamics of TRPV1 and TRPV4 Channels in Living Cells. | 9.84e-07 | 2 | 35 | 2 | 34445178 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19619644 | ||
| Pubmed | Functional TRPV2 and TRPV4 channels in human cardiac c-kit(+) progenitor cells. | 9.84e-07 | 2 | 35 | 2 | 26865051 | |
| Pubmed | Distribution of TRPV1 and TRPV2 in the human stellate ganglion and spinal cord. | 9.84e-07 | 2 | 35 | 2 | 25641129 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 25761879 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19959465 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 18552442 | ||
| Pubmed | Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance. | 9.84e-07 | 2 | 35 | 2 | 24322617 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 21994383 | ||
| Pubmed | A capsaicin-receptor homologue with a high threshold for noxious heat. | 9.84e-07 | 2 | 35 | 2 | 10201375 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 34804016 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19029406 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 1.07e-06 | 340 | 35 | 6 | 11875048 | |
| Pubmed | 1.07e-06 | 340 | 35 | 6 | 11802173 | ||
| Pubmed | 1.12e-06 | 343 | 35 | 6 | 32295537 | ||
| Pubmed | 1.18e-06 | 346 | 35 | 6 | 14611657 | ||
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 1.86e-06 | 24 | 35 | 3 | 33884443 | |
| Pubmed | 2.11e-06 | 25 | 35 | 3 | 16382100 | ||
| Pubmed | 2.69e-06 | 27 | 35 | 3 | 16460286 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 25301060 | ||
| Pubmed | Transient receptor potential channels in pulmonary chemical injuries and as countermeasure targets. | 2.95e-06 | 3 | 35 | 2 | 32892378 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 26763435 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 23147107 | ||
| Pubmed | Oxidative stress mediates thalidomide-induced pain by targeting peripheral TRPA1 and central TRPV4. | 2.95e-06 | 3 | 35 | 2 | 33317522 | |
| Pubmed | Molecular determinants of permeation through the cation channel TRPV4. | 2.95e-06 | 3 | 35 | 2 | 12093812 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 19482060 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 31487269 | ||
| Pubmed | Loss of interneuron LTD and attenuated pyramidal cell LTP in Trpv1 and Trpv3 KO mice. | 2.95e-06 | 3 | 35 | 2 | 23536486 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 12016205 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 29985973 | ||
| Pubmed | Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit. | 2.95e-06 | 3 | 35 | 2 | 17154252 | |
| Pubmed | Parathyroid Hormone-Related Peptide Elicits Peripheral TRPV1-dependent Mechanical Hypersensitivity. | 2.95e-06 | 3 | 35 | 2 | 29497363 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 17920294 | ||
| Pubmed | Functional characterization of transient receptor potential channels in mouse urothelial cells. | 2.95e-06 | 3 | 35 | 2 | 20015940 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 18754773 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 28782273 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 24981230 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 25911511 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 28905239 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 26043006 | ||
| Pubmed | Mechanistic link between diesel exhaust particles and respiratory reflexes. | 2.95e-06 | 3 | 35 | 2 | 28532657 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 35095413 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 35666427 | ||
| Pubmed | OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum. | 2.95e-06 | 3 | 35 | 2 | 17932042 | |
| Pubmed | TRPA1 mediates damage of the retina induced by ischemia and reperfusion in mice. | 2.95e-06 | 3 | 35 | 2 | 32801314 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 27252474 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 30386208 | ||
| Pubmed | 4.99e-06 | 33 | 35 | 3 | 19834762 | ||
| Pubmed | Transcriptional landscape of TRPV1, TRPA1, TRPV4, and TRPM8 channels throughout human tissues. | 5.90e-06 | 4 | 35 | 2 | 36126722 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 24868547 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 17521436 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 29057902 | ||
| Pubmed | Mechanisms of Broad-Band UVB Irradiation‒Induced Itch in Mice. | 5.90e-06 | 4 | 35 | 2 | 33812858 | |
| Pubmed | Glycinergic input of widefield, displaced amacrine cells of the mouse retina. | 5.90e-06 | 4 | 35 | 2 | 19528249 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 9051263 | ||
| Pubmed | Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers. | 5.90e-06 | 4 | 35 | 2 | 28883437 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 21486797 | ||
| Pubmed | Expression Profiles of ASIC1/2 and TRPV1/4 in Common Skin Tumors. | 5.90e-06 | 4 | 35 | 2 | 34199609 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 22865090 | ||
| GeneFamily | Transient receptor potential cation channels | 1.18e-05 | 28 | 29 | 3 | 249 | |
| GeneFamily | Glycine receptors | 2.48e-05 | 5 | 29 | 2 | 868 | |
| GeneFamily | Transmembrane channel likes | 6.91e-05 | 8 | 29 | 2 | 1135 | |
| GeneFamily | Olfactory receptors, family 8 | 2.79e-03 | 49 | 29 | 2 | 155 | |
| GeneFamily | Ankyrin repeat domain containing | 6.69e-03 | 242 | 29 | 3 | 403 | |
| ToppCell | (7)_Monocyte|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.65e-05 | 196 | 35 | 4 | 0232167559dcd2d86ee8b78017cf5f2a084b2cb7 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.03e-05 | 77 | 35 | 3 | a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Sla|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.51e-04 | 132 | 35 | 3 | ddebc0b233fdbb73ceb70187945bbed8fd273f2a | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Ptrf|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.54e-04 | 133 | 35 | 3 | a1bc34e5dda4ff4716b857931cc196f6770f58f4 | |
| ToppCell | Control-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 1.72e-04 | 138 | 35 | 3 | b7920c9a28d28220e7e4b30cd91ba13d0548eb76 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.87e-04 | 142 | 35 | 3 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-04 | 143 | 35 | 3 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 2.03e-04 | 146 | 35 | 3 | 1cb2e157222631e8915d89b255a843d16d7d99cc | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.03e-04 | 146 | 35 | 3 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 2.29e-04 | 152 | 35 | 3 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.47e-04 | 156 | 35 | 3 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 158 | 35 | 3 | 2cfa6dd36c8ae534cf1dd49366d4b4433388c1e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 158 | 35 | 3 | 0c9bb7f8d080a052ca71701544a076c6c2ea67cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 158 | 35 | 3 | cebb58878b6945074bc1c7d5848d842da5dcbae1 | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.56e-04 | 158 | 35 | 3 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.71e-04 | 161 | 35 | 3 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 2.71e-04 | 161 | 35 | 3 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 162 | 35 | 3 | 2787be283b7a705647058aeb9bc54006ce5ffe95 | |
| ToppCell | Control-APC-like-Monocytes|Control / group, cell type (main and fine annotations) | 2.81e-04 | 163 | 35 | 3 | 4bc80a2c741d462724b6f3902377d48c57478932 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_PSRC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-04 | 165 | 35 | 3 | 6de69b75174731931e7e80a3488f983a7ba4defe | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 166 | 35 | 3 | 03a47b8687f54955e84df1edcb230db332c4ca8f | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 3.12e-04 | 169 | 35 | 3 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-04 | 170 | 35 | 3 | 3cbeea6bfa500928c413b1c6129f6dedc769cd1e | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 170 | 35 | 3 | 8d3c51364a332020810836e2055c60893c10d7f3 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.17e-04 | 170 | 35 | 3 | df1a34a69ae404c56f00751a01f52359535f5469 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-mDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-04 | 172 | 35 | 3 | cc0e2a45fa74ee19e41612c3615729462474003a | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 177 | 35 | 3 | d445167dae956e641386f84ab3ae9f47c089e09a | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 177 | 35 | 3 | 4a697866ed542d3201714234cee03451adf1dcc9 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 177 | 35 | 3 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 178 | 35 | 3 | 0b456ac768e026c3ecd5a9a4f43d6f126e7685a1 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-04 | 182 | 35 | 3 | 1fb9bdf2e9f0a9c230f109b471672f9c31e27c82 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 183 | 35 | 3 | 2f0dcc65ad4d90ef946919b4462280fdd20c5ea0 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 183 | 35 | 3 | 0f02136359787bd78146617990968baa47a65d86 | |
| ToppCell | Nasal_Brush-Immune-Dendritic_cells|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.94e-04 | 183 | 35 | 3 | b1daec831990a53e846c089cebfcf4f8440820e4 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-04 | 184 | 35 | 3 | c451acfcd8fe28c1f4b1ea334b1129fa84a15c42 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Neutrophil|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.06e-04 | 185 | 35 | 3 | 655fb705d7a029844ecb4f6a53e948e37ee81006 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-04 | 185 | 35 | 3 | 00a991e63e9ac6de3f48a96e3be6073f90cbb442 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 4.13e-04 | 186 | 35 | 3 | d7da5edb2ee36f96cdd7e27eb9afcc1cbfd52bb6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.26e-04 | 188 | 35 | 3 | 3e94d105ca96ceb5fdcca39a8050217913bc02da | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.33e-04 | 189 | 35 | 3 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | ff7874cc005760a8f3b2e8072fbe418b6bfacaa8 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | 9c5d88f0d3c834c2419ec3da74652175153ba9df | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.46e-04 | 191 | 35 | 3 | 1e668d67bc254ea15518e2c7a029a61087609b7a | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | a7494191a92984e5f53610bbbedd6714e9169e1c | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-04 | 192 | 35 | 3 | 22f335e6e75a694cdccafe189b5ee7815ef28c03 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | eb9a0b3d32f90f8b95905c740aab21639dae5cbd | |
| ToppCell | Monocytes-Inflammatory_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.53e-04 | 192 | 35 | 3 | 4be5c2c946337cd3e710137726358adca563f146 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic-Nonclassical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 4.60e-04 | 193 | 35 | 3 | dc309c249d569e93dc2b154e002212a6eee44497 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-04 | 193 | 35 | 3 | cb0fb21510124883e716780bea46575620c366b8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.60e-04 | 193 | 35 | 3 | f492ed02a46f3a45dc6005f9f18ab12a84bfa2a3 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-04 | 193 | 35 | 3 | 0c207879f994c227dcd1322faa69ec9e3749cdaa | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-04 | 193 | 35 | 3 | 0fbbfcc803edc3cd96b35467ad5cc573af07fd67 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.67e-04 | 194 | 35 | 3 | f1cabb198ab32deaf299899c5e8f42d861b8c574 | |
| ToppCell | medial-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.67e-04 | 194 | 35 | 3 | 202e5070728191c46161fa7d931f00be1c7559d4 | |
| ToppCell | Nasal_Brush-Immune|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.67e-04 | 194 | 35 | 3 | 3135bc4a8112c5dee108e3b8e775f508b65191f1 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.67e-04 | 194 | 35 | 3 | 002cd317732fc6b0d9a72fb46199f71db5a638a7 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.67e-04 | 194 | 35 | 3 | ac203d388a3a3884e316dec0dcbd408e43c6ef6c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-04 | 195 | 35 | 3 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-04 | 195 | 35 | 3 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-04 | 195 | 35 | 3 | 01da7115e38c280fb0baff2032b62bdb609bad5e | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-04 | 195 | 35 | 3 | f5351932634d5913688b15f16da76198c91e9b53 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.74e-04 | 195 | 35 | 3 | 935461e849ca4d17627341b3ae5124d497793a91 | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 4.74e-04 | 195 | 35 | 3 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-04 | 195 | 35 | 3 | aa3914e277918299dc7d2995c0c72288462ad43d | |
| ToppCell | distal-1-Hematologic-Nonclassical_Monocyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.74e-04 | 195 | 35 | 3 | e1a8171d1af53c2bbda758170c5053d3a3bb6ddd | |
| ToppCell | distal-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.74e-04 | 195 | 35 | 3 | 34bed73e4dae34b0f1076b7ff9dc7ea2096c1796 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-04 | 195 | 35 | 3 | c264b052bc50c5bd92816e12fbbe08014d2002f4 | |
| ToppCell | LAM-Myeloid-Monocyte|LAM / Condition, Lineage and Cell class | 4.74e-04 | 195 | 35 | 3 | 7ef400e068e730e18bbdb86f2daa7caf82602349 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.74e-04 | 195 | 35 | 3 | c96755d2eb98112b703b5dbee9c88730ace7dcbf | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.81e-04 | 196 | 35 | 3 | 7e136975e5943d42d51d8cc91c912547ef79cf4d | |
| ToppCell | BLOOD--(3)_Non_classical_monocytes| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.81e-04 | 196 | 35 | 3 | b5ce99e27c9e87be52c10c022a665bf4df0e8b05 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.81e-04 | 196 | 35 | 3 | 89ff93cbfbe39fbdf2498e8fdc5d61a0ecb26fc9 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 4.81e-04 | 196 | 35 | 3 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | proximal-3-Hematologic-Nonclassical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.81e-04 | 196 | 35 | 3 | e426d02c6bcff2358a45e627cc86389070a4af25 | |
| ToppCell | Multiple_Sclerosis-Myeloid-CD16_Mono|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.81e-04 | 196 | 35 | 3 | 83011b56780295dff5ded57064b07dcd2f19ea26 | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.81e-04 | 196 | 35 | 3 | 439d695526714772971fd1a4a92b8b6a84eee1a4 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.81e-04 | 196 | 35 | 3 | 09574bfeb1d3da53b5471cfb0602946d328b3b5c | |
| ToppCell | myeloid-CD16+_Monocyte|World / Lineage and Cell class | 4.81e-04 | 196 | 35 | 3 | 225c102e0a2047425a7125eba1d2359159c50409 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Nonclassical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 4.88e-04 | 197 | 35 | 3 | dcf1e74b7c21466d38d68f44d404bce14ade2805 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 4.88e-04 | 197 | 35 | 3 | 67f19dd30adb03300f04219d0295bc1c1788f626 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.88e-04 | 197 | 35 | 3 | eecb693367510da20a6b1e9355e68785a1e3b85c | |
| ToppCell | Healthy-Non-classical_Monocyte|Healthy / disease group, cell group and cell class | 4.95e-04 | 198 | 35 | 3 | 394e5fa8998c46c6f7cd57b53f347d2029c75ae1 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.95e-04 | 198 | 35 | 3 | 9b47585653aaebd033c9b7bba93c7a7c35a4d60e | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | 4.95e-04 | 198 | 35 | 3 | 8449934e20bb2a34079fb642cae0d4647b9efe51 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.95e-04 | 198 | 35 | 3 | 8b5d30312bbcabc6911ff03e5028766d77203dff | |
| ToppCell | Healthy-Non-classical_Monocyte|World / disease group, cell group and cell class | 4.95e-04 | 198 | 35 | 3 | 4fd27a9fb3758c94ed9f0a726296e92b0625da44 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.95e-04 | 198 | 35 | 3 | cbbdd44dfa95370c0fbaa65ba71d86bfee0ea379 | |
| ToppCell | Control-Myeloid-Non-classical_Monocyte|Control / Disease group, lineage and cell class | 4.95e-04 | 198 | 35 | 3 | ae0a51e63e2751a6d9dc0c8a3852680949173523 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.95e-04 | 198 | 35 | 3 | 9430ce7016b1a4724de036aab3e3e4082d24e436 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.95e-04 | 198 | 35 | 3 | 4f167a52fc87bd5e6cfee3a82177d924f417d025 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.95e-04 | 198 | 35 | 3 | 7d8fade2583c07a33dd83057cbce08e9fc77987a | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 4.95e-04 | 198 | 35 | 3 | 8a97c8b2a43e6d1e669ce18752841e2006744bd9 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.95e-04 | 198 | 35 | 3 | a7eed9eeb728a8796e2780090cc244856efd8c65 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.95e-04 | 198 | 35 | 3 | 3bc3dbd178043deadd7eef413b2761dc003abd6e | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.95e-04 | 198 | 35 | 3 | 165d60b111a17d517a420c434733eefb98da240d | |
| ToppCell | Control-Myeloid|Control / Disease group, lineage and cell class | 5.03e-04 | 199 | 35 | 3 | 5c9d29426f8b4cc813174378a3aefc18a1ae00cc | |
| ToppCell | Healthy_donor-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 5.03e-04 | 199 | 35 | 3 | 45e9099a13becb1e235435ceaaffb92b82ce34ee | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-04 | 199 | 35 | 3 | 0a9783808528bc4c6d797d849a9177330c8fb867 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.03e-04 | 199 | 35 | 3 | 91c72e06a7416671977430211c57938e39e8195e | |
| Computational | AcetylCholine receptors. | 1.87e-04 | 14 | 16 | 2 | MODULE_328 | |
| Computational | Genes in the cancer module 267. | 2.16e-04 | 15 | 16 | 2 | MODULE_267 | |
| Computational | Neurotransmitter (GABA) receptor. | 2.16e-04 | 15 | 16 | 2 | MODULE_215 | |
| Computational | Ion channels. | 7.13e-04 | 27 | 16 | 2 | MODULE_214 | |
| Drug | PPAHV | 2.52e-08 | 5 | 32 | 3 | CID003035862 | |
| Drug | drimanial | 5.03e-08 | 6 | 32 | 3 | CID000636975 | |
| Drug | isovelleral | 8.79e-08 | 7 | 32 | 3 | CID000037839 | |
| Drug | N-oleoyldopamine | 4.13e-07 | 11 | 32 | 3 | CID005282106 | |
| Drug | CID5148062 | 5.50e-07 | 12 | 32 | 3 | CID005148062 | |
| Drug | tinyatoxin | 9.08e-07 | 14 | 32 | 3 | CID000005481 | |
| Drug | polygodial | 9.08e-07 | 14 | 32 | 3 | CID000072503 | |
| Drug | resiniferonol | 2.03e-06 | 18 | 32 | 3 | CID000162824 | |
| Drug | zingerone | 2.41e-06 | 19 | 32 | 3 | CID000031211 | |
| Drug | phorbol-12,13-dibenzoate | 2.83e-06 | 20 | 32 | 3 | CID000072294 | |
| Drug | noladin ether | 3.30e-06 | 21 | 32 | 3 | CID006483057 | |
| Drug | AC1L28IG | 5.00e-06 | 24 | 32 | 3 | CID000042760 | |
| Drug | rac Lafutidine | 5.68e-06 | 25 | 32 | 3 | CID000003873 | |
| Drug | AC1MU7EP | 5.74e-06 | 3 | 32 | 2 | CID003661571 | |
| Drug | propofol | 6.60e-06 | 191 | 32 | 5 | CID000004943 | |
| Drug | Virginiamycin S1 | 8.07e-06 | 28 | 32 | 3 | CID000122731 | |
| Drug | NSC 255317 | 9.98e-06 | 30 | 32 | 3 | CID000099644 | |
| Drug | borate | 1.06e-05 | 98 | 32 | 4 | CID000007628 | |
| Drug | iso-THAZ | 1.15e-05 | 4 | 32 | 2 | CID003047783 | |
| Drug | SC-48981 | 1.15e-05 | 4 | 32 | 2 | CID000126573 | |
| Drug | protostrychnine | 1.15e-05 | 4 | 32 | 2 | CID005320746 | |
| Drug | 7-nitroindoline | 1.15e-05 | 4 | 32 | 2 | CID013566747 | |
| Drug | SC-50132 | 1.15e-05 | 4 | 32 | 2 | CID000195719 | |
| Drug | 2-(phosphonomethyl)phenylalanine | 1.15e-05 | 4 | 32 | 2 | CID000383689 | |
| Drug | SC-49648 | 1.15e-05 | 4 | 32 | 2 | CID000195696 | |
| Drug | SR 42641 | 1.15e-05 | 4 | 32 | 2 | CID000129049 | |
| Drug | akuammiline | 1.15e-05 | 4 | 32 | 2 | CID005367018 | |
| Drug | NSC381080 | 1.15e-05 | 4 | 32 | 2 | CID000165497 | |
| Drug | N-methyl-THIP | 1.15e-05 | 4 | 32 | 2 | CID000134373 | |
| Drug | bosentan | 1.44e-05 | 106 | 32 | 4 | CID000104865 | |
| Drug | ICS-205,930 | 1.90e-05 | 37 | 32 | 3 | CID000005595 | |
| Drug | azetidine-3-carboxylic acid | 1.91e-05 | 5 | 32 | 2 | CID000093192 | |
| Drug | Lindane | 1.91e-05 | 5 | 32 | 2 | DB00431 | |
| Drug | Cao C | 1.91e-05 | 5 | 32 | 2 | CID000166617 | |
| Drug | oxanilide | 1.91e-05 | 5 | 32 | 2 | CID000069288 | |
| Drug | ALX1393 | 1.91e-05 | 5 | 32 | 2 | CID016078939 | |
| Drug | iso-THAO | 1.91e-05 | 5 | 32 | 2 | CID000127199 | |
| Drug | pleiocarpamine | 1.91e-05 | 5 | 32 | 2 | CID000558637 | |
| Drug | mafoprazine | 1.91e-05 | 5 | 32 | 2 | CID000071241 | |
| Drug | gevotroline | 1.91e-05 | 5 | 32 | 2 | CID000060546 | |
| Drug | non-amide | 1.91e-05 | 5 | 32 | 2 | CID000070709 | |
| Drug | N-arachidonoyl-dopamine | 2.23e-05 | 39 | 32 | 3 | CID005282105 | |
| Drug | C09179 | 2.23e-05 | 39 | 32 | 3 | CID000442082 | |
| Drug | tetradotoxin | 2.55e-05 | 428 | 32 | 6 | CID000020382 | |
| Drug | thiomuscimol | 2.86e-05 | 6 | 32 | 2 | CID000005448 | |
| Drug | THAZ | 2.86e-05 | 6 | 32 | 2 | CID000171289 | |
| Drug | mV GABA | 2.86e-05 | 6 | 32 | 2 | CID000128435 | |
| Drug | albaconol | 2.86e-05 | 6 | 32 | 2 | CID005317148 | |
| Drug | caged glycine | 2.86e-05 | 6 | 32 | 2 | CID000192642 | |
| Drug | brometone | 2.86e-05 | 6 | 32 | 2 | CID000006424 | |
| Drug | thio-THIP | 2.86e-05 | 6 | 32 | 2 | CID000656720 | |
| Drug | AC1L90PQ | 2.86e-05 | 6 | 32 | 2 | CID000436036 | |
| Drug | minaxolone | 2.86e-05 | 6 | 32 | 2 | CID000071960 | |
| Drug | cannabidiol | 3.00e-05 | 43 | 32 | 3 | CID000026346 | |
| Drug | thiourea | 3.03e-05 | 128 | 32 | 4 | CID002723790 | |
| Drug | palmitoylethanolamide | 3.21e-05 | 44 | 32 | 3 | CID000004671 | |
| Drug | propyl methanethiosulfonate | 4.00e-05 | 7 | 32 | 2 | CID000529387 | |
| Drug | alpha-EMTBL | 4.00e-05 | 7 | 32 | 2 | CID000128423 | |
| Drug | thiocolchicoside | 4.00e-05 | 7 | 32 | 2 | CID000072067 | |
| Drug | L-serinamide | 4.00e-05 | 7 | 32 | 2 | CID000101138 | |
| Drug | Boc-glycine | 4.00e-05 | 7 | 32 | 2 | CID000078288 | |
| Drug | CID189778 | 4.00e-05 | 7 | 32 | 2 | CID000189778 | |
| Drug | PK 8165 | 4.00e-05 | 7 | 32 | 2 | CID000071219 | |
| Drug | glutamate | 4.20e-05 | 962 | 32 | 8 | CID000000611 | |
| Drug | elaidamide | 4.45e-05 | 49 | 32 | 3 | CID000001930 | |
| Drug | AC1L1G0K | 4.45e-05 | 49 | 32 | 3 | CID000003473 | |
| Drug | Camphor | 5.32e-05 | 52 | 32 | 3 | CID000002537 | |
| Drug | WT702 | 5.33e-05 | 8 | 32 | 2 | CID000089643 | |
| Drug | isostrychnine | 5.33e-05 | 8 | 32 | 2 | CID000264626 | |
| Drug | Glyceryl Arachidonate | 5.33e-05 | 8 | 32 | 2 | CID005282281 | |
| Drug | R1-methanandamide | 5.63e-05 | 53 | 32 | 3 | CID000001293 | |
| Drug | allicin | 5.96e-05 | 54 | 32 | 3 | CID000065036 | |
| Drug | Atonik | 6.85e-05 | 9 | 32 | 2 | CID000069471 | |
| Drug | nortropanol | 6.85e-05 | 9 | 32 | 2 | CID000068147 | |
| Drug | DCQX | 6.85e-05 | 9 | 32 | 2 | CID000001845 | |
| Drug | AC1NSJX8 | 6.85e-05 | 9 | 32 | 2 | CID005311059 | |
| Drug | NSC129536 | 6.85e-05 | 9 | 32 | 2 | CID000004815 | |
| Drug | SR 57227A | 6.85e-05 | 9 | 32 | 2 | CID000131746 | |
| Drug | amiloride | 7.28e-05 | 315 | 32 | 5 | CID000016230 | |
| Drug | SR 48968 | 7.38e-05 | 58 | 32 | 3 | CID000104974 | |
| Drug | OMDM-2 | 8.55e-05 | 10 | 32 | 2 | CID003906781 | |
| Drug | THBA | 8.55e-05 | 10 | 32 | 2 | CID000130993 | |
| Drug | urethane | 8.96e-05 | 169 | 32 | 4 | CID000005641 | |
| Drug | Russian VX | 9.01e-05 | 62 | 32 | 3 | CID000178033 | |
| Drug | AC1L1I1P | 9.01e-05 | 62 | 32 | 3 | CID000004385 | |
| Drug | C17H19NO3 | 9.46e-05 | 63 | 32 | 3 | CID000004840 | |
| Drug | ip 0 | 1.04e-04 | 11 | 32 | 2 | CID000006943 | |
| Drug | resiniferatoxin | 1.09e-04 | 66 | 32 | 3 | CID000104826 | |
| Drug | Neuromedin L. | 1.24e-04 | 69 | 32 | 3 | CID000055582 | |
| Drug | colchicoside | 1.25e-04 | 12 | 32 | 2 | CID000092763 | |
| Drug | SR144528 | 1.29e-04 | 70 | 32 | 3 | CID003081355 | |
| Drug | AM251 | 1.29e-04 | 70 | 32 | 3 | CID000002125 | |
| Drug | 4 alpha-phorbol 12,13-didecanoate | 1.29e-04 | 70 | 32 | 3 | CID000452543 | |
| Drug | evodiamine | 1.47e-04 | 73 | 32 | 3 | CID000151289 | |
| Drug | AC1MIUVB | 1.48e-04 | 13 | 32 | 2 | CID003080371 | |
| Drug | glyceryl nonivamide | 1.48e-04 | 13 | 32 | 2 | CID003035784 | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 6957_DN | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 3904_DN | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 5730_UP | |
| Drug | quinoxaline-2,3-dione | 1.72e-04 | 14 | 32 | 2 | CID011469229 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TVASVLLLLFLLMYI | 176 | Q86XQ3 | |
| LMLGILLAYRIILVF | 676 | Q5T601 | |
| LMLGIYASIFLLLLI | 696 | O43306 | |
| MIFVLGLIYLVLLLL | 841 | O43306 | |
| LIMILVYLRIYLIAK | 186 | P18089 | |
| GLVLIILYVFYILIM | 231 | Q8NFF2 | |
| YLIQMYIPSLLIVIL | 256 | O75311 | |
| YVVLMLLLYVTYTRL | 666 | O75427 | |
| FLIVLVSYMLILLAI | 211 | Q8NH50 | |
| YLFLLLLLIYLMTVL | 26 | Q8NGY5 | |
| LLLIYLMTVLGNLLI | 31 | Q8NGY5 | |
| LLIFVYLNMILLYLL | 171 | Q9UPQ8 | |
| LIYLTAVLMNLVIIL | 31 | Q8NGZ2 | |
| LLMLLLFLSELQYYL | 36 | Q9Y282 | |
| FTVMISLYLLLLLIV | 291 | Q8N5Y8 | |
| LYLYLSLGTLELALM | 101 | Q8NGU1 | |
| MALLLLLLLLLLYKY | 526 | P07333 | |
| MALSVLVLLLLAVLY | 26 | O15432 | |
| FLLLLISYTVILVML | 211 | Q15615 | |
| VYFALILVMYLVILI | 56 | Q8NGS6 | |
| ALFILFLLIYLITML | 26 | Q8NGG4 | |
| ILPAVLLLFMLIYYL | 686 | Q7Z5M5 | |
| MYLLLLLKSVVYFAI | 141 | P0CF51 | |
| YSLPQYMIALLKILL | 511 | Q9ULQ0 | |
| YLIQMYIPSLLIVIL | 251 | P23415 | |
| VIFLLLIYISIMYRE | 236 | Q96K19 | |
| YYLALLLSLLVMVIS | 301 | Q15738 | |
| MLRVSSLVLYIILIY | 631 | Q9Y6L6 | |
| MSLLLLLLLVSYYVG | 1 | Q9H6B4 | |
| TYLLIFILLMIIALQ | 501 | O95498 | |
| IIYLSILGLLLLYMV | 106 | Q9NQ34 | |
| ILGLLLLYMVYLTLV | 111 | Q9NQ34 | |
| LLYMVYLTLVEPILK | 116 | Q9NQ34 | |
| IILLLAYVILTYILL | 661 | Q8NER1 | |
| AYVILTYILLLNMLI | 666 | Q8NER1 | |
| MVLLLLLAYVLLTYI | 621 | Q9Y5S1 | |
| LLAYVLLTYILLLNM | 626 | Q9Y5S1 | |
| IIPAILLMFLAIYYL | 761 | Q8TDI7 | |
| YLLLQTYVLRLEAIM | 106 | Q9P0N5 | |
| TYIILTFVLLLNMLI | 701 | Q9HBA0 | |
| LLYILIYNREMLLLS | 756 | Q96C45 |